US › Healthcare

Alvotech (ALVO)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$5.34+4.71%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$105.8M

Revenue YoY

-38.9%

Net profit

$-66.8M

Profit YoY

-308.6%

EPS

$-0.11

EPS estimate

$-0.06

Net margin

-63.2%

EPS came in at -0.11 against a street estimate of -0.06 — a miss of 83.3%.

Key statistics

Market cap

$1.87B

Forward P/E

7.9

P/B

0.00

Book value

$-0.54

EPS (TTM)

$-0.62

52-week high

$9.25

52-week low

$2.94

50-day MA

$4.02

200-day MA

$4.15

Beta

0.22

Analyst view

Analysts rate Alvotech a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $6.00.

Shareholding

Insiders

59.68%

Institutions

12.72%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Alvotech — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.